B18.0
Chronic viral hepatitis B with delta-agent
Clinical Classification Guidelines
Medical Intelligence & Overview
Chronic viral hepatitis B with delta-agent, also known as hepatitis D superinfection, is a liver infection caused by the hepatitis B virus (HBV) in conjunction with the hepatitis D virus (HDV). This condition complicates the underlying hepatitis B infection and can lead to more severe liver problems. It represents a significant health concern due to its potential to accelerate liver damage and increase the risk of complications such as cirrhosis and liver failure.
Causes & Symptoms
Clinical Causes: Co-infection with hepatitis B virus and hepatitis D virus Exposure to contaminated blood or body fluids Sharing needles or syringes for drug injection Unprotected sexual contact with an infected person Mother-to-child transmission during childbirth Use of contaminated medical equipment
Key Symptoms: Fatigue and weakness Jaundice (yellowing of the skin and eyes) Dark urine and pale stool Abdominal pain or discomfort Nausea and vomiting Loss of appetite Elevated liver enzymes on blood tests Swelling in the abdomen (ascites) Itching of the skin Joint pain or discomfort
Diagnostic & Treatment
Diagnosis Path: Diagnosis of chronic hepatitis B with delta-agent typically involves a combination of blood tests and clinical evaluation. Key diagnostic procedures include:
Treatment Protocols: Managing chronic hepatitis B with delta-agent focuses on controlling viral replication, preventing liver damage, and reducing complications. Treatment options include:
Clinical Advice & FAQs
Billing Guidance
Is B18.0 a billable ICD-10 code?
Yes, B18.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B18.0?
Clinical documentation must specify the nature of Chronic viral hepatitis B with delta-agent and any associated comorbidities for accurate reporting.
Cite this Clinical Reference